Finding new ways to treat the novel coronavirus and its ever-changing variants has been a challenge for researchers, especially when the traditional drug development and discovery process can take years. Researchers are taking a hi-tech approach to determine whether drugs already on the market can pull double duty in treating new COVID variants.